-Live Mint The kharif crop may improve by 8.1% to 135 million tonnes, after falling by 2% last year due to weak monsoon Foodgrain production in India's kharif season, the summer crop, is estimated to increase by a little more than 8% this year on expectations of normal monsoon rains, boosting hopes of a recovery in Asia's third largest economy and a decline in food price inflation. The kharif crop may improve by...
More »SEARCH RESULT
Total Matching Records found : 4031
DBT scheme to be launched in 20 districts-Sujay Mehdudia
-The Hindu It is likely to be extended to entire country from October The Petroleum and Natural Gas Ministry on Wednesday announced that the Direct Benefit Transfer (DBT) scheme for the LPG consumers, putting subsidy cash directly into the account of beneficiaries, would be launched in 20 districts with high Aadhaar card penetration from June 1. The scheme is likely to be extended to the entire country from October this year. However, the...
More »Aadhaar–LPG linkage still tardy in Andhra Pradesh
-The Hindu ‘Consumers must get Aadhaar number linked todatabase of oil Companies and bank accounts' Hyderabad: Even as the Centre announced that the rollout of direct transfer of the cash subsidy on LPG would be from June 1, only 55 per cent of consumers got their Aadhaar number linked to the database of oil Companies in the five districts in Andhra Pradesh. Even poorer is the linkage of Aadhaar numbers to the bank...
More »Reforms’ unintended fallout -Ashoak Upadhyay
-The Hindu Business Line A mint-fresh working paper by the Reserve Bank of India once again trains the spotlight on a problem that, for five decades, every policy-maker has planned to snuff out, failed to, and then wished it would go away if ignored. But financial exclusion simply hasn't, and we now have the central bank applying its forensic skills to an examination of its magnitude. The title of Working Paper Series...
More »Ranbaxy fined $500 m for flawed generics-Narayan Lakshman
-The Hindu Ranbaxy, one of India's largest pharmaceutical Companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came...
More »
